Formulation and Characterization of Novel Ionizable and Cationic Lipid Nanoparticles for the Delivery of Splice‐Switching Oligonucleotides
Abstract
AbstractDespite increasing knowledge about the mechanistic aspects of lipid nanoparticles (LNPs) as oligonucleotide carriers, the structure‐function relationship in LNPs has been generally overlooked. Understanding this correlation is critical in the rational design of LNPs. Here, a materials characterization approach is utilized, applying structural information from small‐angle X‐ray scattering experiments to design novel LNPs focusing on distinct lipid organizations with a minimal compositional variation. The lipid phase structures are characterized in these LNPs and their corresponding bulk lipid mixtures with small‐angle scattering techniques, and the LNP‐cell interactions in vitro with respect to cytotoxicity, hemolysis, cargo delivery, cell uptake, and lysosomal swelling. An LNP is identified that outperforms Onpattro lipid composition using lipid components and molar ratios which differ from the gold standard clinical LNPs. The base structure of these LNPs has an inverse micellar phase organization, whereas the LNPs with inverted hexagonal phases are not functional, suggesting that this phase formation may not be needed for LNP‐mediated oligonucleotide delivery. The importance of stabilizer choice for the LNP function is demonstrated and super‐resolution microscopy highlights the complexity of the delivery mechanisms, where lysosomal swelling for the majority of LNPs is observed. This study highlights the importance of advanced characterization for the rational design of LNPs to enable the study of structure‐function relationships.
Article Details
Authors (10)
Miina Ojansivu
Department of Medical Biochemistry and Biophysics Karolinska Institute Huddinge Stockholm 171 77 Sweden
Hanna M. G. Barriga
Department of Medical Biochemistry and Biophysics Karolinska Institute Huddinge Stockholm 171 77 Sweden
Margaret N. Holme
Division of Chemical Biology
Stefanie Morf
Department of Medical Biochemistry and Biophysics Karolinska Institute Huddinge Stockholm 171 77 Sweden
James J. Doutch
ISIS Neutron and Muon Source Rutherford Appleton Laboratory Harwell Campus Oxfordshire OX11 0QX UK
Samir El Andaloussi
Tomas Kjellman
Camurus AB Rydbergs torg 4 Lund 224 84 Sweden
Markus Johnsson
Camurus AB Rydbergs torg 4 Lund 224 84 Sweden
Justas Barauskas
Camurus AB Rydbergs torg 4 Lund 224 84 Sweden
Molly M. Stevens